SCIENTURE HOLDINGS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $442.24K.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $2.70M.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2025-03-31 was $1.08M, a 75.74% decline year-over-year.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $4.45M, a 6910.87% increase year-over-year.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2025 was $4.31M, a 6.27% decline from fiscal 2024.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2024 was $4.60M, a 1683.86% increase from fiscal 2023.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2023 was $257.77K, a 1.44% increase from fiscal 2022.
- SCIENTURE HOLDINGS, INC. stock issued during period, value, issued for services for fiscal 2022 was $254.11K, a 40.26% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2025-12-31 | $4.31M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $442.24K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.70M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $1.08M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $4.60M 10-K · filed 2026-03-30 | |
| 2024-03-31 | $4.45M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $257.77K 10-K · filed 2025-03-26 | |
| 2023-06-30 | $15.81K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $63.49K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $254.11K 10-K · filed 2024-04-22 | |
| 2022-09-30 | $63.13K 10-Q · filed 2024-01-16 | |
| 2022-06-30 | $12.22K 10-Q · filed 2024-01-16 | |
| 2022-03-31 | $32.08K 10-Q · filed 2024-01-16 | |
| 2021-12-31 | $181.16K 10-K · filed 2023-03-27 | |
| 2021-09-30 | $41.25K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $100.42K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $98.25K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $1.36M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $348.25K 10-Q · filed 2021-10-25 | |
| 2020-06-30 | $829.87K 10-Q · filed 2021-10-25 | |
| 2017-12-31 | $12.50K 10-K · filed 2019-03-22 | |
| 2017-03-31 | $12.50K 10-Q · filed 2017-05-15 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |